drugset / Trial / NCT00420342

Effects of Angeliq and Prempro on Blood Pressure and Sodium Sensitivity in Postmenopausal Women With Prehypertension

NCT00420342

Phase 2 Completed 92 enrolled Bayer
RandomizedParallel-groupDouble-blindTreatment

Summary

The main purpose of this study is to compare the effects of treatment of two different formulations of Angeliq® and Prempro on blood pressure in post-menopausal women with prehypertension.

Timeline

Start
2007-01
Primary completion
2008-09
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Subject 17ß-estradiol Unknown 1 mg
Comparator conjugated estrogens Other / unclassified 0.3 mg
Subject drospirenone Unknown 0.5 mg
Subject drospirenone Unknown 2 mg
Comparator medroxyprogesterone acetate Other / unclassified 1.5 mg

Indications